Anika Therapeutics, Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-K405
10-Q
10-Q/A
10KSB
10KSB40
10QSB
11-K
11-K/A
3
3/A
4
4/A
424B1
424B3
8-A12B
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFR14A
DFAN14A
POS AM
PRE 14A
PREC14A
PRER14A
PRRN14A
S-3
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001171843-25-001467 | Mar 13, 2025 | Mar 11, 2025 |
| 4 | — | 0001171843-25-001468 | Mar 13, 2025 | Mar 11, 2025 |
| 4 | — | 0001171843-25-001470 | Mar 13, 2025 | Mar 11, 2025 |
| 8-K | FORM 8-K | 0001171843-25-001437 | Mar 12, 2025 | — |
| 4 | — | 0001171843-25-001406 | Mar 11, 2025 | Mar 10, 2025 |
| 8-K | FORM 8-K | 0001171843-25-001388 | Mar 11, 2025 | Mar 7, 2025 |
| 4 | — | 0001171843-25-001404 | Mar 11, 2025 | Mar 10, 2025 |
| 4 | — | 0001171843-25-001405 | Mar 11, 2025 | Mar 10, 2025 |
| SCHEDULE 13G/A | — | 0002012383-25-001508 | Feb 5, 2025 | — |
| SCHEDULE 13G/A | — | 0000354204-25-000493 | Jan 23, 2025 | — |
| SC 13G/A | — | 0002012383-24-003689 | Nov 8, 2024 | — |
| 10-Q | FORM 10-Q | 0001171843-24-005993 | Nov 4, 2024 | Sep 30, 2024 |
| 8-K | FORM 8-K | 0001171843-24-005922 | Oct 31, 2024 | — |
| 8-K | FORM 8-K | 0001171843-24-005923 | Oct 31, 2024 | — |
| SC 13G/A | — | 0002012383-24-001796 | Oct 23, 2024 | — |
| 4 | — | 0001171843-24-005510 | Oct 4, 2024 | Oct 1, 2024 |
| 10-Q | FORM 10-Q | 0001171843-24-004615 | Aug 8, 2024 | Jun 30, 2024 |
| 8-K | FORM 8-K | 0001171843-24-004607 | Aug 8, 2024 | — |
| 4 | — | 0001171843-24-003910 | Jul 11, 2024 | Jul 9, 2024 |
| 4 | — | 0001171843-24-003909 | Jul 11, 2024 | Jul 9, 2024 |
| 8-K | FORM 8-K | 0001171843-24-003900 | Jul 11, 2024 | Jul 9, 2024 |
| 4 | — | 0001171843-24-003903 | Jul 11, 2024 | Jul 9, 2024 |
| 4 | — | 0001171843-24-003908 | Jul 11, 2024 | Jul 9, 2024 |
| 4 | — | 0001171843-24-003904 | Jul 11, 2024 | Jul 9, 2024 |
| 4 | — | 0001171843-24-003905 | Jul 11, 2024 | Jul 9, 2024 |
| 4 | — | 0001171843-24-003906 | Jul 11, 2024 | Jul 9, 2024 |
| 4 | — | 0001171843-24-003907 | Jul 11, 2024 | Jul 9, 2024 |
| DEFA14A | DEFA14A | 0001171843-24-003640 | Jun 25, 2024 | — |
| DEF 14A | DEF 14A | 0001193125-24-159219 | Jun 11, 2024 | Jul 9, 2024 |
| ARS | ARS | 0001193125-24-159222 | Jun 11, 2024 | Dec 31, 2023 |
| 4 | — | 0001171843-24-003315 | Jun 5, 2024 | Jun 3, 2024 |
| 3 | — | 0001171843-24-003312 | Jun 5, 2024 | May 28, 2024 |
| 3 | — | 0001171843-24-003310 | Jun 5, 2024 | May 28, 2024 |
| 3 | — | 0001171843-24-003311 | Jun 5, 2024 | Jun 3, 2024 |
| 4 | — | 0001171843-24-003313 | Jun 5, 2024 | Jun 3, 2024 |
| 4 | — | 0001171843-24-003314 | Jun 5, 2024 | Jun 3, 2024 |
| S-8 | FORM S-8 | 0001171843-24-003188 | May 31, 2024 | — |
| SC 13D/A | ANIKA THERAPEUTICS, INC. | 0000902664-24-003936 | May 30, 2024 | — |
| 8-K | FORM 8-K | 0001171843-24-003136 | May 28, 2024 | — |
| 10-Q | FORM 10-Q | 0001171843-24-002682 | May 8, 2024 | Mar 31, 2024 |
| 8-K | FORM 8-K | 0001171843-24-002672 | May 8, 2024 | — |
| 8-K | FORM 8-K | 0001171843-24-002673 | May 8, 2024 | May 2, 2024 |
| 10-K/A | FORM 10-K/A | 0001171843-24-002274 | Apr 26, 2024 | Dec 31, 2023 |
| SC 13G/A | — | 0001086364-24-007359 | Apr 5, 2024 | — |
| 4 | — | 0001171843-24-001458 | Mar 19, 2024 | Mar 15, 2024 |
| 4 | — | 0001171843-24-001459 | Mar 19, 2024 | Mar 15, 2024 |
| 4 | — | 0001171843-24-001460 | Mar 19, 2024 | Mar 15, 2024 |
| 4 | — | 0001171843-24-001461 | Mar 19, 2024 | Mar 15, 2024 |
| 10-K | FORM 10-K | 0001171843-24-001380 | Mar 15, 2024 | Dec 31, 2023 |
| 8-K | FORM 8-K | 0001171843-24-001322 | Mar 13, 2024 | — |